Chemical Structure (Cisatracurium 01)
Cisatracurium Besylate Injection, Solution
Product Images NDC 0409-1098
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0409-1098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Cisatracurium 02)
Not available.*
Figure 2 (Cisatracurium 03)
Logo (Cisatracurium 04)
Principal Display Panel (5 mL Vial Label)
This is a warning and usage description for a single-dose vial of the paralyzing agent cisatracurium besylate. It cautions users to discard any unused portion and to have artificial respiration equipment immediately available. The vial should be refrigerated and protected from light, but not frozen. The vial contains 10mg/5mL of sterile, nonpyrogenic liquid, including cisatracurium besylate and benzenesulfonic acid, and is distributed by Hospira. The text also includes lot and expiration date information.*
Principal Display Panel (5 mL Vial Carton)
Cisatracurium Besylate Injection is a medication in the form of single-dose vials used for intravenous injection. This medication is a paralyzing agent, and it is essential to discard any unused portion. The NDC code of the product is 0409-1098-02, and it is suitable only for prescription use. The instructions and warnings on the label should be followed without exception while administering the medication.*
Principal Display Panel (20 mL Vial Label)
Cisatracurium Besylate injection is a paralyzing agent intended for ICU use only, administered by IV injection. Each 20 mL vial contains 200mg of cisatracurium besylate, with each mL containing 10mg/mL. The unused portion of the single-dose vial should be discarded. A warning indicates that cisatracurium besylate could cause respiratory arrest and facilities must have artificial respiration available immediately. The pH is adjusted by adding benzenesulfonic acid. The vial must be refrigerated between 2-8°C (36-46°F) and should not be frozen. Once removed from the refrigerator, the vial must be used within 21 days, even if re-refrigerated. Finally, Hospira distributes cisatracurium in the USA, and the vial has an NDC code of 0409-1103-T, LOT/EXP HHEHHHAA, DMMMYYYY.*
Principal Display Panel (20 mL Vial Carton)
This is a description for Cisatracurium Besylate injection, which comes as a 200mg 20mL single-dose vial, for ICU and IV injection use only. It is a paralyzing agent, therefore facilities must be immediately available for artificial respiration. Each mL contains cisatracurium besylate that has 10mg cisatracurium, water for injection. It should be stored at 21-28°C (36-46°F); it is sterile, nonpyrogenic, and distributed by Hospira, Inc in Lake Forest, USA.*
Principal Display Panel (10 mL Vial Label)
This is a medication called Cisatracurium Besylate, supplied in a multiple-dose vial, with each mL containing 2mg of Cisatracurium Besylate and 0.9% benzyl alcohol added as a preservative. It's a paralyzing agent, typically administered via IV injection, which requires facilities equipped to respond to respiratory arrest. The vial comes with a warning label and prescribing information, including storage instructions. The medication is distributed by Hospira, Inc. and has a lot number and an expiration date.*
Principal Display Panel (10 mL Vial Carton)
This text appears to be a product description for a medication called Cisatracurium Besylate Injection. It comes in a package containing 10 vials of 10 mL each, with a National Drug Code of 0409-1208-01. The medication is indicated for use as a paralyzing agent via intravenous injection and contains benzyl alcohol as a preservative. Each vial contains 20 mg of medication, which is equivalent to 2 mg/mL. The product is sterile and nonpyrogenic and should be discarded following proper protocols.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
